Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Agata Wieczorkiewicz-Kabut, MD PhD, Sylwia Mizia, MSci, Mariusz Matyja, MD, Krzysztof Bialas, MD, Grzegorz Helbig, MD PhD Prof., Anna Koclega, MD PhD, Malwina Rybicka, MD, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2014) 124 (21): 5934.

https://doi.org/10.1182/blood.V124.21.5934.5934

Published: 2014

Journal Articles

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Malgorzata Sobczyk-Kruszelnicka, Miroslaw Markiewicz, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Agnieszka Wieclawek, Anna Soja, Monika Dzierzak-Mietla, MD, Anna Koclega, Krzysztof Bialas, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2012) 120 (21): 4494.

https://doi.org/10.1182/blood.V120.21.4494.4494

Published: 2012

Journal Articles

The Favorable Results of Allo-HSCT in TKI-Resistant CML,

Miroslaw Markiewicz, MD, PhD, Monika Dzierzak-Mietla, MD, Katarzyna Wisniewska-Piaty, MD, Andrzej Frankiewicz, MD, Anna Koclega, MD, Patrycja Zielinska, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Malgorzata Sobczyk-Kruszelnicka, MD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien

Blood (2011) 118 (21): 4145.

https://doi.org/10.1182/blood.V118.21.4145.4145

Published: 2011

Journal Articles

The Kinetics of Transforming Growth Factor beta1 mRNA Expression and Its Serum Concentration in Graft-Versus-Host Disease After Allogeneic Hemopoietic Stem Cell Transplantation for Myeloid Leukemias.

Patrycja Zielinska, Grzegorz Helbig, Agata Wieczorkiewicz, Slawomira Krzemien

Blood (2009) 114 (22): 4479.

https://doi.org/10.1182/blood.V114.22.4479.4479

Published: 2009

Journal Articles

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, Dr of Biol Sci, Jerzy Wojnar, MD, Assoc., Agata Wieczorkiewicz, MD, Iwona Wylezol, MD, PhD, Sebastian Giebel, MD, PhD, Agnieszka Karolczyk, Biol., Jerzy Holowiecki, MD

Blood (2006) 108 (11): 3156.

https://doi.org/10.1182/blood.V108.11.3156.3156

Published: 2006

NARROW

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

The Favorable Results of Allo-HSCT in TKI-Resistant CML,

The Kinetics of Transforming Growth Factor beta1 mRNA Expression and Its Serum Concentration in Graft-Versus-Host Disease After Allogeneic Hemopoietic Stem Cell Transplantation for Myeloid Leukemias.

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Email alerts

ASH Publications

American Society of Hematology

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

The Favorable Results of Allo-HSCT in TKI-Resistant CML,

The Kinetics of Transforming Growth Factor beta1 mRNA Expression and Its Serum Concentration in Graft-Versus-Host Disease After Allogeneic Hemopoietic Stem Cell Transplantation for Myeloid Leukemias.

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only